...
机译:P2.06-023 A III期研究将Gefitinib和插入的顺铂加上吉替尼与Gefitinib进行EGFR-突变的高级非鳞状NSCLC的研究
Department of Thoracic Oncology National Cancer Center Hospital;
Jcog Data Center/operations Office Center for Research Administration and Support National Cancer;
Jcog Data Center/operations Office Center for Research Administration and Support National Cancer;
Department of Thoracic Oncology National Cancer Center Hospital East;
Department of Thoracic Oncology Kansai Medical University;
Wjog Datacenter;
Third Department of Internal Medicine Wakayama Medical University;
Department of Thoracic Oncology National Cancer Center Hospital;
机译:P2.06-023 A III期研究将Gefitinib和插入的顺铂加上吉替尼与Gefitinib进行EGFR-突变的高级非鳞状NSCLC的研究
机译:一线培美曲塞加顺铂联合吉非替尼维持治疗与吉非替尼单药治疗在东亚患有局部晚期或转移性非鳞状非小细胞肺癌的东亚患者:一项随机的3期临床研究
机译:P1.01-20期III研究将Gefitinib(g)与Gefitinib与Carboplatin和Pemetrexed(GCP)与EGFR突变(NEJ009)相结合的研究
机译:吉非替尼或培美曲塞联合卡铂治疗EGFR突变的晚期肺腺癌的III期研究
机译:P1.01-20期III研究将Gefitinib(g)与Gefitinib与Carboplatin和Pemetrexed(GCP)与EGFR突变(NEJ009)相结合的研究